Pallavi Jha, New Delhi: The second wave of Corona in the country has brought good news amid the outcry. The Serum Institute has announced a price reduction of the Corona Vaccine Covishield. The Serum Institute has lowered the vaccine prices for the state government. Now a dose of this vaccine will be given to the states for 300 rupees instead of 400 rupees. The company’s CEO Adar Poonawala gave this information by tweeting.
Serum Institute CEO Adar Puranala wrote on Twitter, “In the spirit of philanthropy on behalf of the Serum Institute of India, I am reducing the price of the vaccine fixed for the states from Rs 400 per dose to Rs 300 per dose.” Changes in prices have come into force immediately. This will save hundreds of crores of rupees from the state governments, which will allow the vaccine to reach even more people, as well as save countless lives. ‘
Although the serum has reduced the price of a single dose of vaccine only for state governments, the prices for private hospitals have not come down. Private hospitals will still get one dose of Kovishield for Rs 600 only.
Earlier, the Central Government has intervened on the proposal of both the Corona vaccine companies Serum Institute of India (SII) and Bharat Biotech to offer vaccines at higher prices to states and private hospitals. According to sources, on Monday, in a long meeting held under the chairmanship of Cabinet Secretary Rajiv Gauba, all issues were discussed and after that companies were asked to reduce their prices.
Let us tell you that the Serum Institute of India is manufacturing the Oxford-AstraZeneca vaccine. Currently, there are two vaccines available in the country, Kovishield and Bharat Biotech’s Kovaxin. The third phase of corona vaccination is starting from May 1 in the country. Under this, all people above 18 years of age will be vaccinated.